News
2424 posts · page 66 of 101
Study Confirms No Link Between Covid Vaccines and Miscarriage
Despite recent claims, extensive data confirms Covid vaccines are safe and not linked to miscarriage.
Belém's Battle: Reducing Dengue Through Community Efforts
Belém, Brazil's proactive measures against a dengue outbreak offer insights for U.S. cities.
5-Year-Old Maddie Fries Stabilizes After 14-Month Chemotherapy Journey
Diagnosed with neurofibromatosis type 1, Maddie Fries, 5, completes 14 months of chemotherapy for two brain tumors, now stabilized.
American Teen's Death Linked to GLP-1 Weight Loss Drug
A 19-year-old student died from a fatal irregular heartbeat after taking a GLP-1 drug, highlighting potential risks.
Medical Device Industry Opposes India's 2026 Draft Bill
Medical device firms argue the 2026 draft bill equates devices with drugs, risking innovation.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Growth and Expansion
Molbio Diagnostics seeks ₹940 crore through IPO to fund expansion and reduce promoter stake. The firm targets growth in its diagnostics solutions.
Medical Device Industry Opposes Draft Bill Treating Devices as Drugs
India's medical device sector urges government to reconsider draft bill equating devices with drugs, citing potential harm to innovation and investment.
Max Healthcare Reports ₹2982 Cr Revenue, Profit Rises 3% in Q1 FY27
Max Healthcare's Q1 FY27 revenue surged 16% to ₹2,982 crore, with a 3% rise in profit to ₹357 crore, driven by expansions and strategic acquisitions.
Cardiologist Urges Transparency on Trump's Health in Editorial
A cardiologist's editorial calls for more transparency regarding former President Trump's health, citing a lack of public information.
Cheney's Cardiologist Raises Concerns Over Trump's Health
Dr. Jonathan Reiner, former cardiologist to Dick Cheney, questions the transparency of Trump's health disclosures.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fund Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund capital expenditures and reduce promoter stake, eyeing growth in global diagnostics market.
Medical Device Industry Pushes Back Against India's Draft Bill
India's medical device sector criticizes a draft bill that equates devices with pharmaceuticals, citing potential harm to innovation and investment.
Narayana Health Partners with NDB for Global Healthcare Innovation
Narayana Health and NDB collaborate to enhance healthcare through digital and data-driven solutions.
Molbio Diagnostics Seeks ₹940 Crore in IPO to Fuel Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO, reducing promoter stake and boosting global operations.
Effective Home Remedies for Common Aches and Pains
Discover practical tips on choosing the right medication for common aches and pains with guidance from Dr. Akshay Syal.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Targets ₹940 Crore Through IPO for Expansion
Molbio Diagnostics plans IPO to raise ₹940 crore for expansion and promoter stake reduction, appealing to high-risk investors.
Medical Device Industry Opposes India's Draft Regulatory Bill
India's medical device industry opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Molbio Diagnostics IPO: A Risky Opportunity for Long-Term Investors
Molbio Diagnostics seeks ₹200 crore through an IPO, aiming to reduce promoter stake and boost capital expenditures. Is it a high-risk, high-reward investment?
Indian Medical Device Sector Opposes Draft Bill on Regulatory Grounds
India's medical device industry contests a draft bill equating devices with pharmaceuticals, fearing impact on growth and innovation.
Price Caps on Private Healthcare May Hamper Growth, Warns Apollo MD
Apollo's Suneeta Reddy warns that price caps could deter private healthcare investment and innovation, amid government efforts to regulate costs.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, seeking growth in global diagnostics markets.
Medical Device Industry Opposes Indian Draft Bill Over Pharma Treatment
India's medical device sector challenges a draft bill equating devices to drugs, citing regulatory and innovation concerns.
Molbio Diagnostics IPO Seeks ₹940 Crore Amidst Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO, targeting expansion and reducing promoter stake.